Non-familial Hypercholesterolemia and Mixed Hyperlipidemia Clinical Trials in Beijing, Beijing Municipality

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia